Tick-borne viruses: a review from the perspective of therapeutic approaches (Q33415778)

26 July 2017

title

Tick-borne viruses: a review from the perspective of therapeutic approaches (English)

1 reference

26 July 2017

Amin Haghani

3

0 references

Keivan Zandi

object named as

Keivan Zandi

6

0 references

Sazaly AbuBakar

5

object named as

Sazaly AbuBakar

1 reference

26 July 2017

Rafidah Lani

1

1 reference

26 July 2017

Ehsan Moghaddam

2

1 reference

26 July 2017

Li-Yen Chang

4

1 reference

26 July 2017

publication date

21 May 2014

1 reference

Ticks and Tick-borne Diseases

26 July 2017

published in

1 reference

26 July 2017

volume

5

1 reference

26 July 2017

issue

5

1 reference

26 July 2017

page(s)

457-465

1 reference

RNA interference inhibits replication of tick-borne encephalitis virus in vitro

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis complicated by a polio-like syndrome following a holiday in central Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Do specific hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Powassan virus encephalitis, Minnesota, USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne virus diseases of human interest in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

First documented case of imported tick-borne encephalitis in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Zoonotic tick-borne flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Short report: duration of tick attachment required for transmission of powassan virus by deer ticks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Ecology of Colorado tick fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo haemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Treatment of Crimean-Congo hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Viral Encephalitis: Etiology, Clinical Features, Diagnosis and Management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Ribonuclease Treatment of Tick-Borne Encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Sheep Milk-Borne Epidemic of Tick-Borne Encephalitis in Slovakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

Tick-borne flaviviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Field effectiveness of vaccination against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Increased recognition of Powassan encephalitis in the United States, 1999-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Review Article 1: The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa23

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

Kyasanur forest disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

An animal model for the tickborne flavivirus--Omsk hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne viruses in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis: Clinical findings and prognosis in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Coverage and effectiveness of Kyasanur forest disease (KFD) vaccine in Karnataka, South India, 2005-10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tickborne encephalitis despite specific immunoglobulin prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Louping-ill meningo-encephalitis; a further case and a serological survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis in Sweden and climate change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Person-to-person transmission of severe fever with thrombocytopenia syndrome virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis in mainland China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

SiRNA inhibits replication of Langat virus, a member of the tick-borne encephalitis virus complex in organotypic rat brain slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis virus - a review of an emerging zoonosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A new phlebovirus associated with severe febrile illness in Missouri.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis complicated by monoplegia and sensorineural deafness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Other tick-borne illnesses: tularemia, Colorado tick fever, tick paralysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Seroprevalence of Alkhurma and Other Hemorrhagic Fever Viruses, Saudi Arabia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Emergence of Crimean-Congo haemorrhagic fever in Greece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Kyasanur forest disease: an epidemiological view in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-Borne Langat/Mosquito-Borne Dengue Flavivirus Chimera, a Candidate Live Attenuated Vaccine for Protection against Disease Caused by Members of the Tick-Borne Encephalitis Virus Complex: Evaluation in Rhesus Monkeys and in Mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Seasonal synchrony: the key to tick-borne encephalitis foci identified by satellite data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Powassan virus infection: case series and literature review from a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Excretion of louping-ill virus in ewes' milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Transmission of louping-ill virus in goat milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Powassan encephalitis and Colorado tick fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Single-dose vaccine against tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Human arboviral encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

7 January 2021

Omsk haemorrhagic fever.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Epidemiology and ecology of TBE relevant to the production of effective vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tickborne encephalitis in naturally exposed monkey (Macaca sylvanus)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Migrating Birds and Tickborne Encephalitis Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Crimean-Congo hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

A case of tick-borne encephalitis in Japan and isolation of the the virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.04.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TTBDIS.2014.04.001

1 reference

26 July 2017

1 reference